图片: | |
---|---|
名称: | |
描述: | |
姓 名: | ××× | 性别: | 女 | 年龄: | 13 |
标本名称: | |||||
简要病史: | |||||
肉眼检查: | 包膜完整 |
免疫组化:2张CD10、2张CK5、1张p63
病变主要为后两张图中左侧区域表现,制片6张,其中有2张切片中出现微乳头结构
medman_2010 离线
If it is a breast core biopsy, we need to consider the wording. It will decide if excisional biopsy is needed. For this case the 13 y girl had excisional bx already. It makes no difference for the clinical mangment (follow up only) if we report 幼年性纤维腺瘤 or 幼年性纤维腺瘤with ADH.
We should know them meaning of ADH. ADH means the women can have increased ca risk compared with no ADH women.
Pathologists make diagnosis based on the known criteria. If you have a good study with many similar cases with long term follow up and the patients have no increase ca risk, you can say these morphological features in young patients are benign, which should not be called ADH
以下是引用cqzhao在2011-2-5 21:13:00的发言:
If it is a breast core biopsy, we need to consider the wording. It will decide if excisional biopsy is needed. For this case the 13 y girl had excisional bx already. It makes no difference for the clinical mangment (follow up only) if we report 幼年性纤维腺瘤 or 幼年性纤维腺瘤with ADH. We should know them meaning of ADH. ADH means the women can have increased ca risk compared with no ADH women. Pathologists make diagnosis based on the known criteria. If you have a good study with many similar cases with long term follow up and the patients have no increase ca risk, you can say these morphological features in young patients are benign, which should not be called ADH |
谢谢赵老师
本单位按照“纤维腺瘤伴轻中度不典型增生”向临床报告,并注明无需进一步处理,随访即可